377 assets in Pancreatic Neoplasm

Therapeutic assets addressing Pancreatic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Muamycin Pancreatic Neoplasm	Hirschfeld Oncology	P3	CCC (55)
TIL Pancreatic Neoplasm	Intima Bioscience, Inc.	P2	CCC (55)
Adebrelimab Pancreatic Neoplasm	Jinling Hospital, China	P2	CCC (54)
Atezolizumab Pancreatic Neoplasm	Cancer Research UK	P2	CCC (54)
Avutometinib Pancreatic Neoplasm	Washington University School of Medicine	P2	CCC (54)
Cefuroxime Pancreatic Neoplasm	Leiden University Medical Center	P4	CCC (54)
Daraxonrasib Pancreatic Neoplasm	Revolution Medicines, Inc.	P3	CCC (54)
Defactinib Pancreatic Neoplasm	Washington University School of Medicine	P2	CCC (54)
Famitinib Pancreatic Neoplasm	Fudan University	P2	CCC (54)
ibi343 Pancreatic Neoplasm	Zhejiang University	P3	CCC (54)
Ruxolitinib Pancreatic Neoplasm	Incyte Corporation	P3	CCC (54)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Pancreatic Neoplasm	National University of Malaysia	P2	CCC (53)
Anlotinib Capsules Pancreatic Neoplasm	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	P2	CCC (53)
Brigimadlin Pancreatic Neoplasm	Boehringer Ingelheim	P2	CCC (53)
Cabozantinib Pancreatic Neoplasm	Joseph Kim	P2	CCC (53)
Catequentinib Pancreatic Neoplasm	RenJi Hospital	P2	CCC (53)
Hydromorphon Pancreatic Neoplasm	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer Pancreatic Neoplasm	Sensei Biotherapeutics, Inc.	P2	CCC (53)
Lidocaine Pancreatic Neoplasm	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	P2	CCC (53)
Niraparib Pancreatic Neoplasm	Tempus AI	P2	CCC (53)
Olaparib Pancreatic Neoplasm	Cambridge University Hospitals NHS Foundation Trust	P2	CCC (53)
Ponsegromab Pancreatic Neoplasm	Pfizer	P2	CCC (53)
Tamoxifen Pancreatic Neoplasm	Fudan University	P2	CCC (53)
tqb2868 Pancreatic Neoplasm	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	P2	CCC (53)
Utidelone Pancreatic Neoplasm	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	P2	CCC (53)
Gx Pancreatic Neoplasm	Tianjin Medical University Cancer Institute and Hospital	P2/3	CCC (52)
Hydrocortisone Pancreatic Neoplasm	Helsinki University Central Hospital	P4	CCC (52)
Losartan Pancreatic Neoplasm	Tanta University	P2	CCC (52)
Pertuzumab Pancreatic Neoplasm	Cancer Research UK	P2/3	CCC (52)
Propofol Pancreatic Neoplasm	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran	P3	CCC (52)
Surufatinib Pancreatic Neoplasm	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P2	CCC (52)
Tas-102 Pancreatic Neoplasm	National Cancer Institute (NCI)	P2	CCC (52)
Budigalimab Pancreatic Neoplasm	Trishula Therapeutics, Inc.	P2	CCC (51)
Listeria Monocytogenesstrain Strain Crs-207 Pancreatic Neoplasm	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (51)
Atebimetinib Pancreatic Neoplasm	Immuneering Corporation	P3	CCC (50)
Botensilimab Pancreatic Neoplasm	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (50)
hr070803 Pancreatic Neoplasm	Fudan University	P3	CCC (50)
Hrs-4642 Pancreatic Neoplasm	Ruijin Hospital	P2	CCC (50)
Mgnp Pancreatic Neoplasm	Immuneering Corporation	P3	CCC (50)
N-Butyl Cyanoacrylate Pancreatic Neoplasm	Minia University	P3	CCC (50)
qls31905 Pancreatic Neoplasm	Qilu Pharmaceutical Co., Ltd.	P3	CCC (50)
Rivoceranib Pancreatic Neoplasm	Medical College of Wisconsin	P2	CCC (50)
Rmc-6236 Pancreatic Neoplasm	Revolution Medicines, Inc.	P3	CCC (50)
Setidegrasib Pancreatic Neoplasm	Astellas Pharma Global Development, Inc.	P3	CCC (50)
SX682 Pancreatic Neoplasm	Lei Zheng	P2	CCC (50)
TANCIN Pancreatic Neoplasm	OHSU Knight Cancer Institute	P2	CCC (50)
Temuterkib Pancreatic Neoplasm	The Netherlands Cancer Institute	P2	CCC (50)
Tocilizumab Pancreatic Neoplasm	Takeda	P2	CCC (50)
Zoldonrasib Pancreatic Neoplasm	Revolution Medicines, Inc.	P3	CCC (50)
Binimetinib Pancreatic Neoplasm	National Cancer Center, Japan	P2	CCC (49)

Showing 51 to 100 of 377 assets

PreviousPage 2 of 8Next